{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:11:48Z","timestamp":1790478708786,"version":"4.1.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Despite national recommendations, antiviral prescribing in emergency departments (EDs) for children at higher risk of severe influenza, such as those younger than 5 years and those with specific underlying conditions, remains low.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess whether there were changes in antiviral prescribing for children at higher risk of severe influenza in academic pediatric EDs before the COVID-19 pandemic (2016-2020) vs the late pandemic period (2021-2023).<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This multicenter, cross-sectional study included influenza-positive children younger than 18 years presenting to the ED at 1 of 7 US pediatric academic hospitals participating in the Centers for Disease Control and Prevention\u2019s New Vaccine Surveillance Network. The analysis focused on children at higher risk of severe influenza seen in the ED from December 1, 2016, to June 30, 2023.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n High risk of severe influenza.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was antiviral prescribing. Children with influenza who met the criteria for higher risk of severe influenza were included. Antiviral prescribing practices were compared across the prepandemic and late pandemic periods. Mixed-effects logistic regression was used to identify factors associated with prescribing during the late pandemic period.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 3378 influenza-positive children (median [IQR] age, 3.9 [1.8-7.2] years), 2514 (74.4%; 1363 male [40.3%]) were classified as having higher risk of severe influenza during the prepandemic and late pandemic periods. Antiviral prescriptions decreased from 32.2% (622 of 1931 children) before the pandemic to 15.6% (91 of 583 children) in the late pandemic period, representing a 53% relative decrease. In the late pandemic period, symptom duration less than 2 days (adjusted odds ratio, 4.08; 95% CI, 2.49-6.71) and clinical influenza testing (adjusted odds ratio, 17.20; 95% CI, 4.08-72.37) were significantly associated with antiviral prescribing.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This multicenter, cross-sectional study of children with influenza in EDs found that, for children at higher risk of severe influenza illness, influenza antiviral prescribing decreased during the COVID-19 pandemic compared with prepandemic levels, despite unchanged treatment guidelines. Interventions are needed to support guideline-concordant prescribing in this population.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.38729","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:31:24Z","timestamp":1761147084000},"page":"e2538729","source":"Crossref","is-referenced-by-count":6,"title":["Changes in Antiviral Prescribing for Children With Influenza in US Emergency Departments"],"prefix":"10.1001","volume":"8","author":[{"given":"Tess","family":"Stopczynski","sequence":"first","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olla","family":"Hamdan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Z.","family":"Amarin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Antoon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya","family":"Hayek","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chappell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Spieker","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen J.","family":"Klein","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Englund","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Weinberg","sequence":"additional","affiliation":[{"name":"University of Rochester School of Medicine and Dentistry & UR-Golisano Children\u2019s Hospital, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Szilagyi","sequence":"additional","affiliation":[{"name":"University of Rochester School of Medicine and Dentistry & UR-Golisano Children\u2019s Hospital, Rochester, New York"},{"name":"Department of Pediatrics, University of California, Los Angeles, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Williams","sequence":"additional","affiliation":[{"name":"UPMC Children\u2019s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"},{"name":"Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian G.","family":"Michaels","sequence":"additional","affiliation":[{"name":"UPMC Children\u2019s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Boom","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Hospital and Baylor College of Medicine, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila C.","family":"Sahni","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Hospital and Baylor College of Medicine, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Allen","family":"Staat","sequence":"additional","affiliation":[{"name":"Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth P.","family":"Schlaudecker","sequence":"additional","affiliation":[{"name":"Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Schuster","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Missouri-Kansas City, Children\u2019s Mercy Hospital, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangaraj","family":"Selvarangan","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, University of Missouri Kansas City, Children\u2019s Mercy Hospital, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayzsa","family":"Tannis","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi L.","family":"Moline","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Olson","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha B.","family":"Halasa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"1","key":"zoi251072r1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/irv.12486","article-title":"Annual estimates of the burden of seasonal influenza in the United States: a tool for strengthening influenza surveillance and preparedness.","volume":"12","author":"Rolfes","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"zoi251072r3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-050417","article-title":"Influenza antiviral treatment and length of stay.","volume":"148","author":"Campbell","year":"2021","journal-title":"Pediatrics"},{"issue":"11","key":"zoi251072r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.3261","article-title":"Association of early oseltamivir with improved outcomes in hospitalized children with influenza, 2007-2020.","volume":"176","author":"Walsh","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"11","key":"zoi251072r5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1542\/pir.2023-005962","article-title":"Influenza in children and adolescents: epidemiology, management, and prevention.","volume":"44","author":"Wolf","year":"2023","journal-title":"Pediatr Rev"},{"issue":"6","key":"zoi251072r6","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/cid\/ciy874","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"zoi251072r7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-063773","article-title":"Recommendations for prevention and control of influenza in children, 2023-2024.","volume":"152","author":"Committee on Infectious Diseases","year":"2023","journal-title":"Pediatrics"},{"issue":"3","key":"zoi251072r8","doi-asserted-by":"publisher","first-page":"e1040","DOI":"10.1093\/cid\/ciac606","article-title":"Guideline-concordant antiviral treatment in children at high risk for influenza complications.","volume":"76","author":"Antoon","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"3","key":"zoi251072r10","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/j.jemermed.2023.10.007","article-title":"Impact of the COVID-19 pandemic on emergency department encounters in a major metropolitan area.","volume":"66","author":"Stowell","year":"2024","journal-title":"J Emerg Med"},{"issue":"3","key":"zoi251072r11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/irv.12824","article-title":"Influenza and COVID-19: what does co-existence mean?","volume":"15","author":"Chotpitayasunondh","year":"2021","journal-title":"Influenza Other Respir Viruses"},{"issue":"40","key":"zoi251072r12","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.15585\/mmwr.mm7140a1","article-title":"Respiratory virus surveillance among children with acute respiratory illnesses\u2014New Vaccine Surveillance Network, United States, 2016-2021.","volume":"71","author":"Perez","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi251072r13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae573","article-title":"Antiviral use among children hospitalized with laboratory-confirmed influenza illness: a prospective, multicenter surveillance study.","author":"Antoon","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"45","key":"zoi251072r14","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.15585\/mmwr.mm7345a2","article-title":"Underutilization of influenza antiviral treatment among children and adolescents at higher risk for influenza-associated complications\u2014United States, 2023-2024.","volume":"73","author":"Frutos","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"zoi251072r15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/cid\/cix922","article-title":"Influenza antiviral prescribing for outpatients with an acute respiratory illness and at high risk for influenza-associated complications during 5 influenza seasons\u2014United States, 2011-2016.","volume":"66","author":"Stewart","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"zoi251072r16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7706a1","article-title":"Laboratory-confirmed influenza-associated hospitalizations among children and adults\u2014Influenza Hospitalization Surveillance Network, United States, 2010-2023.","volume":"73","author":"Naquin","year":"2024","journal-title":"MMWR Surveill Summ"},{"issue":"6","key":"zoi251072r17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-061960","article-title":"Trends in outpatient influenza antiviral use among children and adolescents in the United States.","volume":"152","author":"Antoon","year":"2023","journal-title":"Pediatrics"},{"issue":"6","key":"zoi251072r18","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13318","article-title":"Association of symptoms and viral culture positivity for SARS-CoV-2-Tennessee, April-July 2020.","volume":"18","author":"Biddle","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"issue":"10","key":"zoi251072r20","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/cid\/cix1040","article-title":"Efficacy and safety of oseltamivir in children: systematic review and individual patient data meta-analysis of randomized controlled trials.","volume":"66","author":"Malosh","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"zoi251072r21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1370\/afm.2183","article-title":"The relationship between oseltamivir and suicide in pediatric patients.","volume":"16","author":"Harrington","year":"2018","journal-title":"Ann Fam Med"},{"issue":"9","key":"zoi251072r22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jamapediatrics.2023.2304","article-title":"Population-based incidence of influenza-associated serious neuropsychiatric events in children and adolescents.","volume":"177","author":"Antoon","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"9","key":"zoi251072r23","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.1093\/cid\/ciaa055","article-title":"Oseltamivir and the risk of neuropsychiatric events: a national, population-based study.","volume":"71","author":"Huh","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10","key":"zoi251072r24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/INF.0000000000004424","article-title":"Incidence of influenza-associated neurologic and psychiatric complications requiring hospitalization in children ages 5-17 years.","volume":"43","author":"Quertermous","year":"2024","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"zoi251072r25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1515\/IJAMH.2009.21.1.79","article-title":"The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza.","volume":"21","author":"Casscells","year":"2009","journal-title":"Int J Adolesc Med Health"},{"issue":"4","key":"zoi251072r26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/pds.845","article-title":"Health outcomes among patients receiving oseltamivir.","volume":"13","author":"Enger","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"zoi251072r27","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S1473-3099(15)70041-1","article-title":"Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial.","volume":"15","author":"Fry","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"zoi251072r28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents.","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi251072r29","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","article-title":"Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.","volume":"20","author":"Ison","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"16","key":"zoi251072r30","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMoa2413156","article-title":"Efficacy of baloxavir treatment in preventing transmission of influenza.","volume":"392","author":"Monto","year":"2025","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi251072r31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19151","article-title":"Comparison of antiviral agents for seasonal influenza outcomes in healthy adults and children: a systematic review and network meta-analysis.","volume":"4","author":"Liu","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi251072r32","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1086\/656408","article-title":"Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial.","volume":"51","author":"Heinonen","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi251072r33","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02246-2019","article-title":"Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care.","volume":"56","author":"Lee","year":"2020","journal-title":"Eur Respir J"},{"issue":"10","key":"zoi251072r34","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/cid\/cix127","article-title":"Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A(H1N1)pdm09 at high risk of hospitalization: an individual participant data metaanalysis.","volume":"64","author":"Venkatesan","year":"2017","journal-title":"Clin Infect Dis"},{"key":"zoi251072r35","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.1995","article-title":"Influenza with and without oseltamivir treatment and neuropsychiatric events among children and adolescents.","author":"Antoon","year":"2025","journal-title":"JAMA Neurol"},{"issue":"5","key":"zoi251072r36","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-069111","article-title":"Variability of clinician recommendations for oseltamivir in children hospitalized with influenza.","volume":"155","author":"Bassett","year":"2025","journal-title":"Pediatrics"},{"issue":"6","key":"zoi251072r37","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-063481","article-title":"Influenza antivirals in pediatrics: why aren\u2019t we using all the available tools?","volume":"152","author":"Pannaraj","year":"2023","journal-title":"Pediatrics"},{"issue":"18","key":"zoi251072r38","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1001\/jama.2023.17244","article-title":"Influenza antiviral shortages reported by state and territorial public health officials, 2022-2023.","volume":"330","author":"Kojima","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"zoi251072r39","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.mayocpiqo.2021.07.005","article-title":"Influenza management during the COVID-19 pandemic: a review of recent innovations in antiviral therapy and relevance to primary care practice.","volume":"5","author":"Jones","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"zoi251072r41","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf178","article-title":"Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024.","author":"Adams","year":"2025","journal-title":"Clin Infect Dis"},{"key":"zoi251072r2","unstructured":"Centers for Disease Control and Prevention. More than 100 flu-related deaths in children reported so far this season. March 8, 2024. Accessed November 18, 2024. https:\/\/www.cdc.gov\/flu\/whats-new\/2023-2024-pediatric-flu-deaths.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/flu\/spotlights\/2023-2024\/pediatric-flu-deaths.htm"},{"key":"zoi251072r9","unstructured":"World Health Organization. Coronavirus disease (COVID-19) pandemic. Accessed November 18, 2024. https:\/\/www.who.int\/europe\/emergencies\/situations\/covid-19"},{"key":"zoi251072r19","unstructured":"Terrie? YC. Tamiflu set to switch to OTC status. Pharmacy Times. December 2019. Accessed March 19, 2025. https:\/\/www.pharmacytimes.com\/view\/tamiflu-set-to-switch-to-otc-status"},{"key":"zoi251072r40","unstructured":"Centers for Disease Control and Prevention. Rapid influenza diagnostic tests. September 17, 2024. Accessed November 18, 2024. https:\/\/www.cdc.gov\/flu\/hcp\/testing-methods\/clinician_guidance_ridt.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2840397\/stopczynski_2025_oi_251072_1760558796.12375.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:31:26Z","timestamp":1761147086000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2840397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.38729","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}